Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 222 Posts
1 2 3 ... 14
Paulson Adds Pretium, Exits United Tech In Q4
Article By: The Fly Sunday, February 16, 2020 12:29 PM EST
John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of December 31, 2019. The fund's top holdings as of December 31, in order of size, were Bausch Health, SPDR Gold Shares, Allergan, Discovery Class C and Horizon Therapeutics
In this article: AGN, CPE, PCG, QEP, S, TIF, UTX, LOGM, DISCK, GOLD, HZNP, TECD, GLD, PVG, CZR, BHC, NMRK, INSW, LYFT
Read
16 Stocks With The Highest Long-Term Sales Growth Rate
Article By: Benzinga Wednesday, October 23, 2019 4:20 PM EST
Longtime investors know the stock market is forward-looking. Here are the 16 S&P 500 stocks with the biggest revenue growth over the past five years.
In this article: AGN, CNC, CRM, LEN, INFO, ABMD, INCY, AVGO, CHTR, NKTR, INFO, FB, TWTR, FANG, ANET, KHC Also: UBER, AMZN, NFLX, TSLA
Read
Allergan Reports Q2 Earnings Beat, Reaffirms Guidance
Article By: Benzinga Tuesday, August 6, 2019 9:06 AM EST
Allergan reported second-quarter earnings of $4.38 per share, which beat the analyst consensus estimate of $4.34 by 0.92%.
In this article: AGN
Read
Long Thesis For Allergan
Article By: ValueWalk Sunday, July 14, 2019 2:43 PM EST
Quintessential Capital's Gabriel Grego recently shared a rare long call for Allergan. This is interesting not only because AGN was once a hot short position due to Bill Ackman, but also because Grego is known for his shorts.
In this article: AGN
Read
3 Dividend Stocks Retirees Must Have In Their Portfolio
Article By: SureDividend Sunday, July 7, 2019 2:18 AM EST
Investing in strong dividend growers will help you live a stress-free retirement. Even if we are currently trading at an all-time high, Mr. Market offers us a few great opportunities. Here are my favorites right now.
In this article: ABT, AGN, ENB, LAZ, ABBV
Read
E American Depositary Receipts
Article By: Vivian Lewis Thursday, June 27, 2019 12:01 AM EST
The medical devices firm Smith & Nephew pondered creating an ADR listing in order to pay their new CEO Narnal Nawana a higher salary than would have been tolerated by UK shareholders. And more on global stocks.
In this article: ANFGF, CRH, GNCGY, MELI, NPSNY, TCEHY, AAIGF, TEVA, AGN, ZYME, VOD, CGEN, GNFTF, BHC, BT, AQN, DCMYY, AZRE, FBASF, GLD
Read
Abbvie To Buy Allergan For $60 Billion In Latest Pharma Megadeal
Article By: Tyler Durden Tuesday, June 25, 2019 7:14 AM EST
Abbvie will pay most of the price, represents a 45% premium over Allergan’s closing share price Monday of $129.57, in cash.
In this article: ABBV, AGN
Read
Allergan Recent Selloff 'Very Much Overdone,' Says JPMorgan
Article By: The Fly Wednesday, June 19, 2019 9:07 AM EST
With Allergan shares down 14% over the last 30 days, JPMorgan analyst Chris Schott calls the recent selloff "very much overdone."
In this article: AGN
Read
Undervalued Growth And Dividend Growth In Health Technology
Article By: Chuck Carnevale Wednesday, March 20, 2019 11:13 AM EST
Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015.
In this article: ABBV, AGN, AMGN, BMY, BIIB, CELG, GILD, MYL, PFE, PRGO
Read
Wall Street's Top Stories For Tuesday, Jan. 29th
Article By: The Fly Tuesday, January 29, 2019 4:08 PM EST
Stocks have mixed day as investors await Apple earnings.
In this article: AGN, EAT, GME, MMM, PCG, PFE, VZ, AAPL, SANM, WWD, FMCC, FNMA, SQ, OCX
Read
How Trump's Policies Moved Stocks - Dec. 23
Article By: The Fly Sunday, December 23, 2018 10:40 PM EST
Trump accuses Facebook, Twitter, and Google of being "biased;" White House blocks tax break for alcohol companies.
In this article: BF-A, FB, GOOGL, GOOG, TWTR, DEO, STZ, BF-B, AGN, AZN, NVS
Read
5 Drug/Biotech Stocks Likely To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research Sunday, October 28, 2018 2:00 PM EST
There are a number of drug/biotech companies poised to surpass third-quarter estimates. However, given the large number of drug/biotech firms, the task of selecting stocks with possibilities to beat could appear quite daunting.
In this article: REGN, AGN, AMGN, ALNY, AMAG
Read
Allergan Says Study Of Higher Doses Of BOTOX Meets Primary Endpoint
Article By: The Fly Friday, September 14, 2018 8:09 PM EST
Allergan announced clinical study results of higher doses of BOTOX Cosmetic compared to BOTOX Cosmetic 20 unit dose at week 24 in patients with moderate to severe glabellar lines.
In this article: AGN
Read
Allergan Upgraded To Buy From Neutral At Mizuho
Article By: The Fly Friday, August 3, 2018 9:31 AM EST
Mizuho analyst Irina Koffler upgraded Allergan to Buy and raised her price target for the shares to $210 from $194.
In this article: AGN
Read
Pharma Stock Roundup: Mixed Q1 For MRK, PFE, FDA Nod For Kymriah's 2nd Indication
Article By: Zacks Investment Research Friday, May 4, 2018 8:15 PM EST
First-quarter results of pharma bigwigs like Pfizer, Merck and Allergan stole the limelight this week. Other than that, Novartis gained FDA approval for the second indication of its CAR-T therapy, Kymriah.
In this article: AGN, JNJ, MRK, NVS, PFE, UTHR, ABBV
Read
Allergan Beats Q1 Earnings, Stock Up
Article By: Zacks Investment Research Monday, April 30, 2018 12:09 PM EST
Allergan’s first-quarter earnings of $3.74 per share were above our consensus estimate of $3.36 per share.
In this article: AGN
Read
1 to 16 of 222 Posts
1 2 3 ... 14